Our study cannot draw any conclusions regarding a possible association between the use of anti-TNF or anti-integrins and the occurrence of urothelial tumors in patients with IBD due to the insufficient number of patients belonging to these groups. The gene discussed is TNF; the disease is inflammatory bowel disease.